Non-alcoholic steatohepatitis (NASH) is the leading cause of liver transplant in US women while pregnancy rates in women with liver disease are also on the rise. In an overview of ‘What’s new in hepatology’, delegates at Australian Gastroenterology Week 2018 were told that NASH was now the most common indication for waitlist registration and liver ...
Women make news in AGW 2018 liver disease update
By Mardi Chapman
10 Sep 2018